HomeZLDAF • OTCMKTS
add
Zelira Therapeutics Ltd
Previous close
$0.45
Year range
$0.19 - $0.69
Market cap
7.26M AUD
Avg Volume
45.00
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 20.11K | -82.05% |
Operating expense | 1.26M | 12.05% |
Net income | -1.22M | -6.03% |
Net profit margin | -6.05K | -490.85% |
Earnings per share | — | — |
EBITDA | -1.27M | -19.02% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 586.16K | 300.91% |
Total assets | 5.18M | -84.71% |
Total liabilities | 9.36M | 329.42% |
Total equity | -4.17M | — |
Shares outstanding | 11.35M | — |
Price to book | -1.12 | — |
Return on assets | -64.53% | — |
Return on capital | -188.33% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -1.22M | -6.03% |
Cash from operations | -1.33M | 27.12% |
Cash from investing | 459.87K | -51.06% |
Cash from financing | 1.13M | 27.69% |
Net change in cash | 260.66K | 4,098.84% |
Free cash flow | -996.57K | -151.52% |
About
Founded
2003
Website
Employees
8
